Market Place
Sourcing Support
Enforcement Report - Week of July 26, 2023
26 Jul 2023 //
FDA
Enforcement Report - Week of July 12, 2023
12 Jul 2023 //
FDA
Delpor to Include Spasticity Maintenance Therapy with $2.5M NIH Grant
16 Nov 2021 //
BUSINESSWIRE
Dr Reddy`s, Zydus Pharma recall products in US market
29 Aug 2021 //
ECONOMICTIMES
Dr Reddy`s Laboratories, Zydus Pharma recall products in US market
29 Aug 2021 //
BUSINESS STANDARD
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Enforcement Report - Week of December 9, 2020
09 Dec 2020 //
FDA
Aurobindo Pharma`s Generic Tizanidine Hydrochloride Receives Approval in US
28 Mar 2020 //
FDA
Aurobindo Pharma share price jumps 11% after US FDA nod for muscle relaxant
27 Mar 2020 //
MONEYCONTROL
Alembic Pharma share price up 2% on USFDA final approval
14 Jan 2020 //
MONEY CONTROL
Alembic Pharmaceuticals` Generic Tizanidine HCL Receives Approval
13 Jan 2020 //
FDA
Dr Reddy`s Labs net zooms by 106% to Rs. 1,950 crore in 2018-19
22 May 2019 //
PHARMABIZ
Alkem Labs Generic Tizanidine Hydrochloride Receives Approval in US
29 Mar 2019 //
FDA
Cadila Pharms Generic Tizanidine Hydrochloride Receives Approval in US
29 Mar 2019 //
FDA
Riconpharma`s Generic Tizanidine Hydrochloride Receives Approval in US
14 Mar 2019 //
FDA
Alkem`s Generic Tizanidine Hydrochloride Receives Approval in US
25 Jan 2019 //
FDA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
Zydus Pharm`s Generic Tizanidine Hydrochloride Receives Approval In US
14 Mar 2018 //
FDA
Zydus Cadila gets USFDA nod for Tizanidine tablets
13 Mar 2018 //
ECONOMIC TIMES
Jubilant`s Generic Tizanidine Hydrochloride Receives Approval In US
09 Aug 2017 //
FDA
Par Pharm’s Generic Tizanidine Hydrochloride Receives Approval In US
14 Mar 2017 //
FDA
Zydus Cadila gets USFDA nod to market muscle relaxant in US
08 Mar 2017 //
ECONOMIC TIMES
Zydus Pharms Usa Inc Generic Tizanidine HCL Receives Approval In US
03 Mar 2017 //
FDA
Par`s Generic Tizanidine HCL Receives Approval In US
26 Jan 2017 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.